Helius Medical Technologies stock (NASDAQ: HSDT) took a dramatic hit on June 13, falling by 45.89% and closing at $0.60 USD, compared to the previous close of $1.11. This significant drop is raising alarms for investors and traders alike. With further declines showing in pre-market trading, it’s crucial to evaluate whether this is a high-risk buying opportunity or a stock to avoid.
Here’s a complete breakdown to help you decide whether to invest in HSDT stock today.
Helius Medical Stock Overview – June 13, 2025
- Open: $0.64
- High: $0.70
- Low: $0.60 (matches the new 52-week low)
- Close: $0.60
- Previous Close: $1.11
- Pre-Market Price: $0.52 (Down 12.92%)
This reflects a total 52-week collapse from a high of $24.00 to just $0.60, now nearing delisting territory if the trend continues.
Fundamental Analysis
- Market Cap: $18.95 million
- P/E Ratio: Not available (likely due to ongoing losses)
- Dividend Yield: None
- 52-Week High: $24.00
- 52-Week Low: $0.60
The company is currently operating with minimal market confidence. The lack of earnings data and absence of dividends indicate weak or unstable fundamentals, which are key concerns for long-term investors.
Technical Indicators
- Trend: Extremely bearish
- Support Level: $0.60 (immediate support, also 52-week low)
- Resistance Level: $0.70
- Volume: Very high volume sell-off signals institutional exit or retail panic.
Unless a reversal pattern or positive catalyst occurs, the trend will likely continue downward in the short term.
Should You Buy Helius Medical Technologies Stock Today?
Reasons to Consider Buying (Highly Speculative):
- Price is at a 52-week low – possible bounce territory for day traders.
- Could attract speculative attention due to high volatility.
- If insider buying or good news breaks, a price surge is possible.
Reasons to Stay Away:
- 45.89% drop in one day shows extreme negative sentiment.
- Pre-market trend still heading down (-12.92%) – more pain likely.
- No dividends, no earnings transparency, and consistent devaluation.
- Risk of NASDAQ non-compliance due to share price under $1.
What Traders Should Watch Today
- News Releases: Look for company updates or SEC filings that explain the price collapse.
- Volume & Price Action: A hold above $0.60 with high volume might signal temporary stabilization.
- Pre-Market Movement: Continued weakness could drag the price further below $0.50.
Final Verdict: Is HSDT Stock a Buy or a Trap?
Helius Medical stock is currently trading like a classic falling knife. The 46% drop in one session with no confirmed news release suggests either insider movement, a failed trial, or dilution fears.
For long-term investors, this stock is extremely high-risk and not recommended without fundamental due diligence. However, high-risk, high-reward traders may consider entering for a scalp if a reversal setup forms—strict stop-loss is essential.
SEO Keywords Used:
- Helius Medical stock today
- HSDT stock crash
- Should I buy Helius Medical Technologies stock
- Penny stock investing June 2025
- Helius stock forecast
